Clinical Trial Update: Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Interleukin-7 for CD4 lymphopenia in metastatic breast cancer and assessing risks of severe hematologic toxicity and tumor progression;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: Centre Leon Berard | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED